Biblio

Export 1356 results:
Author Title [ Type(Asc)] Year
Filters: First Letter Of Last Name is P  [Clear All Filters]
Journal Article
R. Remington, Bechtel, C., Larsen, D., Samar, A., Doshanjh, L., Fishman, P., Luo, Y., Smyers, K., Page, R., Morrell, C., and Shea, T. B., “A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
W. Tajeddinn, Persson, T., Calvo-Garrido, J., Ahmed, M. Seed, Maioli, S., Vijayaraghavan, S., Kazokoglu, M. Selim, Parrado-Fernández, C., Yoshitake, T., Kehr, J., Francis, P., Winblad, B., Höglund, K., Cedazo-Minguez, A., and Aarsland, D., “Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 1, pp. 349-61, 2016.
W. Tajeddinn, Persson, T., Calvo-Garrido, J., Ahmed, M. Seed, Maioli, S., Vijayaraghavan, S., Kazokoglu, M. Selim, Parrado-Fernández, C., Yoshitake, T., Kehr, J., Francis, P., Winblad, B., Höglund, K., Cedazo-Minguez, A., and Aarsland, D., “Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 1, pp. 349-61, 2016.
R. Penninkilampi, Brothers, H. M., and Eslick, G. D., “Pharmacological Agents Targeting γ-Secretase Increase Risk of Cancer and Cognitive Decline in Alzheimer's Disease Patients: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1395-404, 2016.
M. S. Rafii, Lukic, A. S., Andrews, R. D., Brewer, J., Rissman, R. A., Strother, S. C., Wernick, M. N., Pennington, C., Mobley, W. C., Ness, S., and Matthews, D. C., “PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).”, J Alzheimers Dis, vol. 60, no. 2, pp. 439-450, 2017.
I. Rouch, Pongan, E., Leveque, Y., Tillmann, B., Trombert, B., Getenet, J. Claude, Auguste, N., Krolak-Salmon, P., Laurent, B., and Dorey, J. - M., “Personality Modulates the Efficacy of Art Intervention on Chronic Pain in a Population of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 2, pp. 617-624, 2018.
C. L. Parham, Shaw, C., Auckland, L. D., S Dickeson, K., Griswold-Prenner, I., and Bix, G., “Perlecan Domain V Inhibits Amyloid-β Induced Activation of the α2β1 Integrin-Mediated Neurotoxic Signaling Cascade.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1629-1647, 2016.
O. Laugisch, Johnen, A., Maldonado, A., Ehmke, B., Bürgin, W., Olsen, I., Potempa, J., Sculean, A., Duning, T., and Eick, S., “Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 1, pp. 105-114, 2018.
D. Chiasserini, Biscetti, L., Farotti, L., Eusebi, P., Salvadori, N., Lisetti, V., Baschieri, F., Chipi, E., Frattini, G., Stoops, E., Vanderstichele, H., Calabresi, P., and Parnetti, L., “Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.”, J Alzheimers Dis, vol. 54, no. 1, pp. 55-67, 2016.
A. F. Teich, Sakurai, M., Patel, M., Holman, C., Saeed, F., Fiorito, J., and Arancio, O., “PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 295-302, 2016.
L. - S. Liu, Bai, X. - Q., Gao, Y., Wu, Q., Ren, Z., Li, Q., Pan, L. - H., He, N. - Y., Peng, J., and Tang, Z. - H., “PCSK9 Promotes oxLDL-Induced PC12 Cell Apoptosis Through the Bcl-2/Bax-Caspase 9/3 Signaling Pathway.”, J Alzheimers Dis, vol. 57, no. 3, pp. 723-734, 2017.
L. - S. Liu, Bai, X. - Q., Gao, Y., Wu, Q., Ren, Z., Li, Q., Pan, L. - H., He, N. - Y., Peng, J., and Tang, Z. - H., “PCSK9 Promotes oxLDL-Induced PC12 Cell Apoptosis Through the Bcl-2/Bax-Caspase 9/3 Signaling Pathway.”, J Alzheimers Dis, vol. 57, no. 3, pp. 723-734, 2017.
H. Courtemanche, Bigot, E., Pichelin, M., Guyomarch, B., Boutoleau-Bretonnière, C., Le May, C., Derkinderen, P., and Cariou, B., “PCSK9 Concentrations in Cerebrospinal Fluid Are Not Specifically Increased in Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1519-1525, 2018.
A. Pistono, Jucla, M., Barbeau, E. J., Saint-Aubert, L., Lemesle, B., Calvet, B., Köpke, B., Puel, M., and Pariente, J., “Pauses During Autobiographical Discourse Reflect Episodic Memory Processes in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 3, pp. 687-98, 2016.
A. Pistono, Jucla, M., Barbeau, E. J., Saint-Aubert, L., Lemesle, B., Calvet, B., Köpke, B., Puel, M., and Pariente, J., “Pauses During Autobiographical Discourse Reflect Episodic Memory Processes in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 3, pp. 687-98, 2016.
A. Pistono, Jucla, M., Barbeau, E. J., Saint-Aubert, L., Lemesle, B., Calvet, B., Köpke, B., Puel, M., and Pariente, J., “Pauses During Autobiographical Discourse Reflect Episodic Memory Processes in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 3, pp. 687-98, 2016.
G. Fernández, Manes, F., Politi, L. E., Orozco, D., Schumacher, M., Castro, L., Agamennoni, O., and Rotstein, N. P., “Patients with Mild Alzheimer's Disease Fail When Using Their Working Memory: Evidence from the Eye Tracking Technique.”, J Alzheimers Dis, vol. 50, no. 3, pp. 827-38, 2016.
A. C. Robinson, Davidson, Y. S., Horan, M. A., Pendleton, N., and Mann, D. M. A., “Pathological Correlates of Cognitive Impairment in The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age.”, J Alzheimers Dis, 2018.
A. Stojakovic, Chang, S. - Y., Nesbitt, J., Pichurin, N. P., Ostroot, M. A., Aikawa, T., Kanekiyo, T., and Trushina, E., “Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice.”, J Alzheimers Dis, vol. 79, no. 1, pp. 335-353, 2020.
J. J. Iliff, Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., G Vates, E., Deane, R., Goldman, S. A., Nagelhus, E. A., and Nedergaard, M., “A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β.”, Sci Transl Med, vol. 4, no. 147, p. 147ra111, 2012.
J. J. Iliff, Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., G Vates, E., Deane, R., Goldman, S. A., Nagelhus, E. A., and Nedergaard, M., “A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β.”, Sci Transl Med, vol. 4, no. 147, p. 147ra111, 2012.
J. Perła-Kaján, Włoczkowska, O., Zioła-Frankowska, A., Frankowski, M., A Smith, D., de Jager, C. A., Refsum, H., and Jakubowski, H., “Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 81, no. 3, pp. 1211-1229, 2021.
D. W. Scharre, Chang, S. - I., Nagaraja, H. N., Park, A., Adeli, A., Agrawal, P., Kloos, A., Kegelmeyer, D., Linder, S., Fritz, N., Kostyk, S. K., and Kataki, M., “Paired Studies Comparing Clinical Profiles of Lewy Body Dementia with Alzheimer's and Parkinson's Diseases.”, J Alzheimers Dis, vol. 54, no. 3, pp. 995-1004, 2016.
A. Malara, De Biase, G. Andrea, Bettarini, F., Ceravolo, F., Di Cello, S., Garo, M., Praino, F., Settembrini, V., Sgrò, G., Spadea, F., and Rispoli, V., “Pain Assessment in Elderly with Behavioral and Psychological Symptoms of Dementia.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1217-25, 2016.
M. Atee, Hoti, K., Parsons, R., and Hughes, J. D., “Pain Assessment in Dementia: Evaluation of a Point-of-Care Technological Solution.”, J Alzheimers Dis, vol. 60, no. 1, pp. 137-150, 2017.

Pages